Teva Pharmaceutical Industries ADR (TEVA)

$28.19 -0.22 (-0.77%)
Market Cap 30.83B
Revenue (ttm) 16.54B
Net Income (ttm) -1.64B
EPS (ttm) N/A
PE Ratio 10.42
Forward PE 10.61
Profit Margin -9.91%
Debt to Equity Ratio 2.31
Volume 4,083,861
Avg Vol 11,464,384
Day's Range N/A - N/A
Shares Out 1.15B
Stochastic %K 99%
Beta 0.67
Analysts Strong Sell
Price Target $26.89

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 3 914 8213
Address:
124 Dvora HaNevi’a St., Tel Aviv, Israel
WAJeff
WAJeff Dec. 5 at 6:01 PM
$TEVA Just observed that Druck's #3 position is also making a mammoth move (52.4% last three months, 52 week high today). You may just remember getting burned in this after 2015 but it could plug a gap to $37, a level not seen since November 2016.
0 · Reply
thinkandpick
thinkandpick Dec. 5 at 5:23 PM
$TEVA Most investors know the popular Israeli stocks such as $TEVA $CYBR $PERI $SEDG $WIX but they do not know Silynxcom (SYNX). SYNX is an unknown and dirt-cheap Israeli company of the defense industry that recently expanded into the drone detection technology market: https://seekingalpha.com/instablog/526931-value-digger/6231090-silynxcom-ltd-undiscovered-debt-free-very-low-valuation-and-big-growth-potential
0 · Reply
JarvisFlow
JarvisFlow Dec. 5 at 3:02 PM
Scotiabank updates rating for Teva Pharmaceutical Indus ( $TEVA ) to Outperform, target set at 35.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 5 at 12:46 PM
$TEVA RSI: 72.53, MACD: 1.5816 Vol: 1.29, MA20: 25.49, MA50: 22.12 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 11:05 PM
$TEVA Upppsss....
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 10:49 PM
$TEVA Tjek den her video: "what a wonderful world" https://share.google/Jn8u3at9AFe8S9QSc
0 · Reply
SdotRayborn
SdotRayborn Dec. 4 at 10:05 PM
$TEVA give me another gap up 😂
0 · Reply
LakersandVRX
LakersandVRX Dec. 4 at 9:06 PM
$TEVA every sell is being bought up. This has to be institutional buyers. This is going to be a holding in every value and growth fund.
1 · Reply
JawadAbuJaber
JawadAbuJaber Dec. 4 at 8:52 PM
$TEVA $30 calling?🚀
0 · Reply
SdotRayborn
SdotRayborn Dec. 4 at 8:46 PM
$TEVA 😂😂
0 · Reply
Latest News on TEVA
Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 4, 2025, 2:08 PM EST - 23 hours ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

Nov 30, 2025, 3:14 AM EST - 5 days ago

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

INSM NTRA

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Nov 25, 2025, 8:10 AM EST - 10 days ago

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December

Nov 21, 2025, 4:30 PM EST - 13 days ago

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December

Teva seeks startups to help solve global pharmaceutical challenges

Nov 19, 2025, 8:07 AM EST - 16 days ago

Teva seeks startups to help solve global pharmaceutical challenges

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 8:58 AM EST - 17 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Nov 14, 2025, 10:38 AM EST - 21 days ago

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023

Nov 11, 2025, 3:51 AM EST - 24 days ago

Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023

Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 10, 2025, 2:51 PM EST - 24 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 Transcript

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Nov 7, 2025, 6:00 PM EST - 27 days ago

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Why Teva Pharmaceutical Stock Rocked the Market Today

Nov 5, 2025, 5:53 PM EST - 4 weeks ago

Why Teva Pharmaceutical Stock Rocked the Market Today

Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working

Nov 5, 2025, 1:02 PM EST - 4 weeks ago

Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working

Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 1:01 PM EST - 4 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 Earnings Call Transcript

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Nov 5, 2025, 11:30 AM EST - 4 weeks ago

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Teva Pharmaceuticals stock surges 12% as branded drug sales outperform

Nov 5, 2025, 9:14 AM EST - 4 weeks ago

Teva Pharmaceuticals stock surges 12% as branded drug sales outperform

Teva Pharm third-quarter profit tops estimates as branded drugs gain

Nov 5, 2025, 7:44 AM EST - 4 weeks ago

Teva Pharm third-quarter profit tops estimates as branded drugs gain

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Here's Why This Israeli Investment Giant Is Betting $834 Million on Teva Stock

Nov 3, 2025, 10:55 AM EST - 4 weeks ago

Here's Why This Israeli Investment Giant Is Betting $834 Million on Teva Stock

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Oct 31, 2025, 4:30 PM EDT - 4 weeks ago

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Blood pressure medicine recalled over high levels of cancer-causing chemical

Oct 30, 2025, 11:45 AM EDT - 5 weeks ago

Blood pressure medicine recalled over high levels of cancer-causing chemical

Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

Oct 29, 2025, 1:01 PM EDT - 5 weeks ago

Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe

Oct 20, 2025, 4:30 PM EDT - 6 weeks ago

Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe

Teva Vs. Viatris: Who Will Dominate In President Trump's America?

Oct 17, 2025, 12:18 PM EDT - 7 weeks ago

Teva Vs. Viatris: Who Will Dominate In President Trump's America?

VTRS

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2026

Oct 13, 2025, 4:10 AM EDT - 7 weeks ago

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2026

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Oct 10, 2025, 3:00 PM EDT - 7 weeks ago

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside

Oct 7, 2025, 4:07 AM EDT - 2 months ago

Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside

Billionaire Stanley Druckenmiller Sold His Fund's Stakes in Nvidia and Palantir, and Has Piled Into These 2 Phenomenal Stocks for 4 Straight Quarters

Oct 6, 2025, 3:06 AM EDT - 2 months ago

Billionaire Stanley Druckenmiller Sold His Fund's Stakes in Nvidia and Palantir, and Has Piled Into These 2 Phenomenal Stocks for 4 Straight Quarters

TSM

Teva Releases Q3 2025 Aide Memoire

Sep 25, 2025, 4:30 PM EDT - 2 months ago

Teva Releases Q3 2025 Aide Memoire

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

Sep 25, 2025, 4:30 PM EDT - 2 months ago

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors

Sep 25, 2025, 11:42 AM EDT - 2 months ago

Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors

Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 24, 2025, 7:23 AM EDT - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Teva Pharmaceutical Industries Limited - Special Call

Sep 22, 2025, 2:53 PM EDT - 2 months ago

Teva Pharmaceutical Industries Limited - Special Call

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Sep 20, 2025, 10:15 PM EDT - 2 months ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Medincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 Presentation

Sep 17, 2025, 8:00 AM EDT - 2 months ago

Medincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 Presentation

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

Sep 16, 2025, 4:30 PM EDT - 2 months ago

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:57 PM EDT - 3 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Colorado must face Teva's lawsuit over free allergy pen law

Sep 5, 2025, 3:57 PM EDT - 3 months ago

Colorado must face Teva's lawsuit over free allergy pen law

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

Sep 2, 2025, 4:30 PM EDT - 3 months ago

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

US FDA approves Teva Pharmaceuticals' generic obesity drug

Aug 28, 2025, 9:17 AM EDT - 3 months ago

US FDA approves Teva Pharmaceuticals' generic obesity drug

Teva's Pivot To (Innovative) Growth: Re-Rating Should Continue

Aug 28, 2025, 1:43 AM EDT - 3 months ago

Teva's Pivot To (Innovative) Growth: Re-Rating Should Continue

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters

Aug 20, 2025, 3:51 AM EDT - 3 months ago

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters

Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth”

Aug 19, 2025, 9:00 AM EDT - 3 months ago

Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth”

US FDA approves Teva's Ajovy for migraine prevention in children

Aug 5, 2025, 6:16 PM EDT - 4 months ago

US FDA approves Teva's Ajovy for migraine prevention in children

Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside

Jul 31, 2025, 3:27 PM EDT - 4 months ago

Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside

Teva CEO: Our supply chain puts us in a strong position

Jul 30, 2025, 12:40 PM EDT - 4 months ago

Teva CEO: Our supply chain puts us in a strong position

Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:50 AM EDT - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript

Teva Pharm Q2 profit beats estimates as branded drugs gain

Jul 30, 2025, 7:21 AM EDT - 4 months ago

Teva Pharm Q2 profit beats estimates as branded drugs gain

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Jul 29, 2025, 2:44 PM EDT - 4 months ago

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters

Jul 18, 2025, 3:06 AM EDT - 5 months ago

Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters

PLTR TSM

Teva Releases Q2 2025 Aide Memoire

Jun 26, 2025, 4:30 PM EDT - 5 months ago

Teva Releases Q2 2025 Aide Memoire

WAJeff
WAJeff Dec. 5 at 6:01 PM
$TEVA Just observed that Druck's #3 position is also making a mammoth move (52.4% last three months, 52 week high today). You may just remember getting burned in this after 2015 but it could plug a gap to $37, a level not seen since November 2016.
0 · Reply
thinkandpick
thinkandpick Dec. 5 at 5:23 PM
$TEVA Most investors know the popular Israeli stocks such as $TEVA $CYBR $PERI $SEDG $WIX but they do not know Silynxcom (SYNX). SYNX is an unknown and dirt-cheap Israeli company of the defense industry that recently expanded into the drone detection technology market: https://seekingalpha.com/instablog/526931-value-digger/6231090-silynxcom-ltd-undiscovered-debt-free-very-low-valuation-and-big-growth-potential
0 · Reply
JarvisFlow
JarvisFlow Dec. 5 at 3:02 PM
Scotiabank updates rating for Teva Pharmaceutical Indus ( $TEVA ) to Outperform, target set at 35.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 5 at 12:46 PM
$TEVA RSI: 72.53, MACD: 1.5816 Vol: 1.29, MA20: 25.49, MA50: 22.12 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 11:05 PM
$TEVA Upppsss....
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 10:49 PM
$TEVA Tjek den her video: "what a wonderful world" https://share.google/Jn8u3at9AFe8S9QSc
0 · Reply
SdotRayborn
SdotRayborn Dec. 4 at 10:05 PM
$TEVA give me another gap up 😂
0 · Reply
LakersandVRX
LakersandVRX Dec. 4 at 9:06 PM
$TEVA every sell is being bought up. This has to be institutional buyers. This is going to be a holding in every value and growth fund.
1 · Reply
JawadAbuJaber
JawadAbuJaber Dec. 4 at 8:52 PM
$TEVA $30 calling?🚀
0 · Reply
SdotRayborn
SdotRayborn Dec. 4 at 8:46 PM
$TEVA 😂😂
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 8:42 PM
$TEVA past.... xx moving in.
0 · Reply
TheDudeRooster
TheDudeRooster Dec. 4 at 8:31 PM
$TEVA Damn. No Christmas for the bears. You guys can’t share? 😂
1 · Reply
QuantInsider
QuantInsider Dec. 4 at 8:14 PM
What's up with $TEVA Big 5-day rally, up 6.76% That $438.9k Dec 19 call block at the ask is pushing a bullish vibe into December But today’s flow was all puts, 7,574 contracts in Mar 20 26 $22S Looks like some protection into strength, not a bearish signal Plus, management's chat at Citi’s Healthcare Conference could stir things up Keep an eye on that IV
0 · Reply
ProfitMafia
ProfitMafia Dec. 4 at 7:53 PM
I’m looking at another $TEVA PLAY
0 · Reply
FinSUN
FinSUN Dec. 4 at 7:05 PM
$TEVA next selling block just below $30
0 · Reply
Hopewisper
Hopewisper Dec. 4 at 7:03 PM
$TEVA Terradump =TheDudeRooster... grill the stupid assss....
1 · Reply
Nomorelies
Nomorelies Dec. 4 at 6:30 PM
$TEVA last earnings were excellent. Headed up!
0 · Reply
Hshshhssos
Hshshhssos Dec. 4 at 4:38 PM
$TEVA where is terradumb?
0 · Reply
grb6604
grb6604 Dec. 4 at 4:28 PM
$TEVA “The dogs bark, but the caravan goes on”
1 · Reply
TheDudeRooster
TheDudeRooster Dec. 4 at 3:38 PM
$TEVA Hell nah 😂
1 · Reply
LakersandVRX
LakersandVRX Dec. 4 at 3:30 PM
$TEVA So any bear saw this coming? The charts are telling you this should have gone down a long time ago? lol. Where to turn to now? Maybe the stars? Coin flipping? Oh I know, ground hogs.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 2:52 PM
$VTRS $TEVA
0 · Reply